Regencell Bioscience Holdings Ltd (RGC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $2.45B
Last updated: Nov 17, 2026 at 4:38 PM ET
Regencell Bioscience Holdings Ltd (RGC) Stock Chart
Regencell Bioscience Holdings (RGC) has a latest price of $4.72 on Nov 17, 2026, 93.2% below its 52-week high of $69.00. Its price fell 63.7% over the past 12 months. The month-end price rose 1,798.7% over the 5 years through Oct 2026, a compound annual rate of 80.2%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $29.22 in Apr 2026 and its lowest $0.09 in Jun 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RGC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RGC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 13.6%, and over 6 months it fell 83.0%. The month-end price rose 1,500.3% over the 3 years through Oct 2026, a compound annual rate of 152.0%.
| Period | Change |
|---|---|
| 1 month | -50.8% |
| 3 months | -13.6% |
| 6 months | -83.0% |
| 12 months | -63.7% |
| 12 months, with dividends | -63.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +1,500.3% | +152.0% |
| 5 years | +1,798.7% | +80.2% |
Price by Year
Its best calendar year was 2025, when the price rose 16,053.8%, and its weakest was 2023, when it fell 62.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $6.71 | -68.0% |
| 2025 | $21.00 | +16,053.8% |
| 2024 | $0.13 | -52.9% |
| 2023 | $0.28 | -62.4% |
| 2022 | $0.73 | -12.4% |
Trading Range
The price is 30.1% below its 50-day average of $6.75 and 70.3% below its 200-day average of $15.88.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.72 | |
| 52-week high | $69.00 | -93.2% |
| 52-week low | $4.51 | +4.7% |
| 50-day average | $6.75 | -30.1% |
| 200-day average | $15.88 | -70.3% |
Price Risk
Over 3 years, its largest fall from a peak was 94.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.35 |
| Largest fall, 1 year | -91.1% |
| Largest fall, 3 years | -94.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RGC
What is RGC's 1-year price change?
Regencell Bioscience Holdings's price fell 63.7% over the past 12 months. With dividends included, the 12-month total return was -63.7%.
What is RGC's 5-year price change?
Regencell Bioscience Holdings's month-end price rose 1,798.7% over the 5 years through Oct 2026, a compound annual rate of 80.2%. These figures leave out dividends.
What is RGC's 52-week high and low?
Regencell Bioscience Holdings's 52-week high is $69.00 and its 52-week low is $4.51. Its latest price of $4.72 on Nov 17, 2026 is 93.2% below the high.
What is RGC's beta?
Regencell Bioscience Holdings's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 91.1%.
Is the RGC chart free?
Yes. Advanced Charting for RGC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.